Phase I Study of LEE011plus Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Ribociclib (Primary) ; Cetuximab
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 11 Oct 2016 Results assessing safety of ribociclib in combination with cetuximab (n=10) presented at the 41st European Society for Medical Oncology Congress.
- 18 Apr 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 18 Apr 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History